Nav: Home

CAR T-cell therapy for solid tumors may advance cancer treatments

March 25, 2020

The full title of the research is "The study of the mechanisms of effectiveness of T-cells CAR-T towards solid tumors"; it was supported by nonprofit RakFond (Cancer Fund) and CyStoreLab (a resident of Skolkovo).

Immunotherapy with genetically modified lymphocytes, such as CAR-T cells, is one of the most promising branches of modern fundamental and clinical oncology. A CAR-T cell is a T-lymphocyte with a gene encoding a chimeric antigen receptor, or CAR receptor, in its genome.

"To simplify the concept, we can say that a T-cell is a soldier of the regular forces, and a CAR-T cells are special forces performing particularly difficult tasks. At the same time, CAR-T cells can be 'given a command' to destroy almost any type of tumor," explains project lead Emil Bulatov, Associate Professor at the Department of Biochemistry, Biotechnology and Pharmacology, Leading Research Associate at the Gene and Cell Technology Lab.

The process is as follows: tumor cells contain certain "beacon" proteins on their surface, by which CAR-T cells can find them in the human body and destroy them. In the case of hematologic diseases, one of these proteins is CD19, which is located on the surface of B cells. In the case of solid tumors, the HER2, PCSA, ROR1 proteins can serve as such beacons. It is the fight against solid tumors that is one of the most complex and interesting problems in this area.

Currently, there are only two approved biomedical cell preparations based on CAR-T cells for the treatment of hematologic diseases in the world (Kymriah and Yescarta). However, despite the success of CAR-T cell therapy for the treatment of hematologic diseases, the question of its effective use against solid tumors (carcinoma, neuroblastoma, etc.) remains unresolved. This is due to several reasons, such as high heterogeneity of the cell composition of solid tumors, immunosuppressive tumor microenvironment, difficulties in penetrating the tumor stroma, local hypoxia and a lack of nutrients inside the tumor. Given the high prevalence of solid tumors, the search for ways to effectively use CAR-T immunotherapy for their treatment is extremely relevant.

"Together with colleagues, we have already conducted preliminary experiments on xenograft animal models with a seated tumor, and the results are very encouraging. The data obtained on cell models of solid tumors were generally confirmed in subsequent experiments with immunodeficient mice," states Bulatov.

The use of CAR-T cells was non-toxic to mice and resulted in a marked reduction in tumor size.

"We believe that this work will bring us closer to creating domestic CAR-T-cell preparations and to treating cancer patients. The first stages of translating our results into practice will be held at the Center for Precision and Regenerative Medicine of Kazan Federal University," concludes the researcher.
-end-


Kazan Federal University

Related Proteins Articles:

Designing vaccines from artificial proteins
EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines.
New method to monitor Alzheimer's proteins
IBS-CINAP research team has reported a new method to identify the aggregation state of amyloid beta (Aβ) proteins in solution.
Composing new proteins with artificial intelligence
Scientists have long studied how to improve proteins or design new ones.
Hero proteins are here to save other proteins
Researchers at the University of Tokyo have discovered a new group of proteins, remarkable for their unusual shape and abilities to protect against protein clumps associated with neurodegenerative diseases in lab experiments.
Designer proteins
David Baker, Professor of Biochemistry at the University of Washington to speak at the AAAS 2020 session, 'Synthetic Biology: Digital Design of Living Systems.' Prof.
Gone fishin' -- for proteins
Casting lines into human cells to snag proteins, a team of Montreal researchers has solved a 20-year-old mystery of cell biology.
Coupled proteins
Researchers from Heidelberg University and Sendai University in Japan used new biotechnological methods to study how human cells react to and further process external signals.
Understanding the power of honey through its proteins
Honey is a culinary staple that can be found in kitchens around the world.
How proteins become embedded in a cell membrane
Many proteins with important biological functions are embedded in a biomembrane in the cells of humans and other living organisms.
Finding the proteins that unpack DNA
A new method allows researchers to systematically identify specialized proteins called 'nuclesome displacing factors' that unpack DNA inside the nucleus of a cell, making the usually dense DNA more accessible for gene expression and other functions.
More Proteins News and Proteins Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Meditations on Loneliness
Original broadcast date: April 24, 2020. We're a social species now living in isolation. But loneliness was a problem well before this era of social distancing. This hour, TED speakers explore how we can live and make peace with loneliness. Guests on the show include author and illustrator Jonny Sun, psychologist Susan Pinker, architect Grace Kim, and writer Suleika Jaouad.
Now Playing: Science for the People

#565 The Great Wide Indoors
We're all spending a bit more time indoors this summer than we probably figured. But did you ever stop to think about why the places we live and work as designed the way they are? And how they could be designed better? We're talking with Emily Anthes about her new book "The Great Indoors: The Surprising Science of how Buildings Shape our Behavior, Health and Happiness".
Now Playing: Radiolab

The Third. A TED Talk.
Jad gives a TED talk about his life as a journalist and how Radiolab has evolved over the years. Here's how TED described it:How do you end a story? Host of Radiolab Jad Abumrad tells how his search for an answer led him home to the mountains of Tennessee, where he met an unexpected teacher: Dolly Parton.Jad Nicholas Abumrad is a Lebanese-American radio host, composer and producer. He is the founder of the syndicated public radio program Radiolab, which is broadcast on over 600 radio stations nationwide and is downloaded more than 120 million times a year as a podcast. He also created More Perfect, a podcast that tells the stories behind the Supreme Court's most famous decisions. And most recently, Dolly Parton's America, a nine-episode podcast exploring the life and times of the iconic country music star. Abumrad has received three Peabody Awards and was named a MacArthur Fellow in 2011.